Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B

Immunotherapy of patients suffering from the human epidermal growth factor receptor 2 overexpressing (HER-2+) breast cancers with the anti-HER-2 antibodies results in increase of the patients ’ overall survival. H...

Source: Clinical and Translational Medicine - August 18, 2016 Category: Internal Medicine Authors: Marek Malecki, Chelsea Sabo, Afsoon Foorohar and Xenia Tombokan Source Type: research